More Shandong Lukang Pharmaceutical Co., Ltd. Class A news
Shandong Lukang Pharmaceutical Co., Ltd. Class ASSE: 600789

(600789)"Shandong Lukang Pharmaceutical Co., Ltd."Announcement on Adjustment to Certain Senior Executives

Sep 30, 2026 · Issued by Shandong Lukang Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

SSE: 600789

Announcement on Adjustment to Certain Senior Executives

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

View original source (Shanghai Stock Exchange)

Earlier from Shandong Lukang Pharmaceutical Co., Ltd. Class A

  • "Shandong Lukang Pharmaceutical Co., Ltd."Announcement on Obtaining Drug Registration Certificate and Approval Notice for Marketing Application of Chemical APISep 23
  • "Shandong Lukang Pharmaceutical Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance BriefingSep 9
  • "Shandong Lukang Pharmaceutical Co., Ltd."Special Report on the Deposit, Management and Actual Use of Raised FundsAug 29
  • "Shandong Lukang Pharmaceutical Co., Ltd."Announcement on the Controlled Subsidiary Obtaining the Supplementary Application Approval Notice for Crisaborole Ointment and Becoming the Marketing Authorization Holder of the DrugAug 20
All Shandong Lukang Pharmaceutical Co., Ltd. Class A news releases↗